Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Upregulation of Pro-inflammatory Cytokine Genes by Parvovirus B19 in Human Bone Marrow Mesenchymal Stem Cells

  • 114 Accesses

Abstract

Chronic inflammation plays a prominent role in cancer initiation and development. On the other hand, the Inflammation can be established by a number of factors such as viral infections. Parvovirus B19 (B19V) is a pathogen with widespread infection, which infects bone marrow erythroid progenitor cells. It has been shown that B19V can also enter human bone marrow mesenchymal stem cells (BM-MSCs). In this study, we hypothesized that BM-MSCs as the main cellular component of bone marrow niche may be induced to secret pro-inflammatory cytokines after B19V infection. BM-MSCs were cultured up to passage 3. The cells were then subjected to nucleofection to transfer a plasmid containing B19V genome. After 36 h, total RNA was extracted and the expression levels of IL-1β, IL-6, TNF-α and NF-κB genes were examined using qRT-PCR. Data analysis showed the significant increase in expression levels of all studied genes in the B19V-transfected cells (P < 0.05). Although further researches are required, our findings for the first time suggest the importance of B19V infection to establish an inflammatory microenvironment in the bone marrow and its involvement in inflammation-related diseases. Finally, based on our results, molecular assay to diagnose B19V infection of BM-MSCs prior to stem cell therapy is strongly recommended.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Abla O, Gassas A, Stevens R, Grant R, Abdelhaleem M (2006) bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection. J Pediatr Hematol/Oncol 2:98–99

  2. Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, Hobbs JA (2014) Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process. Virus Res 190:8–16

  3. Amorin B, Alegretti AP, Valim V, Pezzi A, Laureano AM, da Silva MAL et al (2014) Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell 27(4):137–150

  4. Anderson L, Young NS (1999) Mono-graphs in virology (Human parvovirus B19). Switzerland 20:17–130

  5. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? The Lancet 357(9255):539–545

  6. Brown K, Young NS (1995) Parvovirus B19 infection and hematopoiesis. Blood 9(3):176–182

  7. Chen R (2008) Molecular mechanisms linking inflammation, cancer and chemoresistance. Yale University, New Heaven

  8. Chen AY, Guan W, Lou S, Liu Z, Kleiboeker S, Qiu J (2010) Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol 84(23):12385–12396

  9. Chen AY, Zhang EY, Guan W, Cheng F, Kleiboeker S, Yankee TM et al (2010) The small 11kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 115(5):1070–1080

  10. Cohen B, Buckley MM (1988) The prevalence of antibody to human parvovirus B 19 in England and Wales. J Med Microbiol 25(2):151–153

  11. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30(7):1073–1081

  12. Cotmore SF, Agbandje-McKenna M, Chiorini JA, Mukha DV, Pintel DJ, Qiu J et al (2014) The family parvoviridae. Arch Virol 159(5):1239–1247

  13. Coussens LM, Zitvogel L, Palucka AK (2013) Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339(6117):286–291

  14. Crusz SM, Balkwill FR (2015) Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 12(10):584

  15. de Martel C, Franceschi S (2009) Infections and cancer: established associations and new hypotheses. Crit Rev Oncol/Hematol 70(3):183–194

  16. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13(11):759

  17. Fan Y, Mao R, Yang J (2013) NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Proteion Cell 4(3):176–185

  18. Fritch Lilla SA, Burgett SE, McGann KA, Wechsler DS (2014) Persistent and prolonged parvovirus B19 viremia in a pediatric patient with acute lymphoblastic leukemia. J Pediatr Infect Dis Soc 4(3):e38–e40

  19. Gallinella G (2013) Parvovirus B19 achievements and challenges. ISRN Virology. https://doi.org/10.5402/2013/898730

  20. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883–899

  21. Heegaard ED, Brown KE (2002) Human parvovirus B19. Clin Microbiol Rev 15(3):485–505

  22. Hsu T-C, Chiu C-C, Chang S-C, Chan H-C, Shi Y-F, Chen T-Y et al (2016) Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice. Virulence 7(2):110–118

  23. Ibrahem WN, Hasony HJ, Hassan JG (2014) Human parvovirus B19 in childhood acute lymphoblastic leukaemia in Basrah. J Pak Med Assoc 64(1):9–12

  24. Jain P, Jain A, Prakash S, Khan DN, Singh DD, Kumar A et al (2015) Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India. J Med Virol 87(2):303–309

  25. Jitschin R, Peters O, Plentz A, Turowski P, Segerer H, Modrow S et al (2011) Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders. Clin Microbiol 17(9):1336–1342

  26. Konopleva MY, Jordan CTJ (2011) Leukemia stem cells and microenvironment: biology and therapeutic targeting. JAMA 29(5):591

  27. Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K et al (2009) Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 49(11):1660–1666

  28. Kühl U, Lassner D, Pauschinger M, Gross U, Seeberg B, Noutsias M et al (2008) Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol 80(7):1243–1251

  29. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MAJ (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. https://doi.org/10.1155/2014/149185

  30. Li Y, Dong Y, Jiang J, Yang Y, Liu K, Li Y (2012) High prevelance of human parvovirus infection in patients with malignant tumors. Oncol Lett 3(3):635–640

  31. Luo Y, Qiu J (2015) Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol 10(2):155–167

  32. Molenaar-de Backer MW, de Waal M, Sjerps MC, Koppelman MH (2016) Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA. Transfusion 56(2):440–448

  33. Pal S, Bhattacharjee A, Ali A, Mandal NC, Mandal SC, Pal M (2014) Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism. J Inflamm 11(1):23

  34. Perwez Hussain S, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121(11):2373–2380

  35. Schetter AJ, Heegaard NH, Harris CC (2009) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31(1):37–49

  36. Servant-Delmas A, Lefrère J-J, Morinet F, Pillet S (2010) Advances in human B19 erythrovirus biology. J Virol 84(19):9658–9665

  37. Sundin M, Lindblom A, Örvell C, Barrett AJ, Sundberg B, Watz E et al (2008) Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation. Biol Blood Marrow Transplant 14(10):1172–1179

  38. Taniguchi K, Karin M (eds) IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Elsevier, Amsterdam.

  39. Tewary SK, Zhao H, Deng X, Qiu J, Tang L (2014) The human parvovirus B19 non-structural protein 1 N-terminal domain specifically binds to the origin of replication in the viral DNA. J Virol 449:297–303

  40. Tolfvenstam T, Broliden K (eds) (2009) Parvovirus B19 infection. Elsevier, Amsterdam

  41. Vasconcelos GM, Christensen BC, Houseman EA, Xiao J, Marsit CJ, Wiencke JK et al (2011) History of parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia. Epigenetics 6(12):1436–1443

  42. Virchow R (1863) Lymphatische Geschwülste. Die Krankhaften Geschwulste. 2: Hirschwald Berlin, p. 563-578.

  43. Waldner MJ, Neurath MF (eds) (2014) Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Elsevier, Amsterdam

  44. Watanabe K, Otabe K, Shimizu N, Komori K, Mizuno M, Katano H et al (2018) High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow. Stem Cell Res Ther 9(1):80

  45. Wong S, Young NS, Brown KE (2003) Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 187(10):1581–1586

  46. Zavattoni M, Paolucci S, Sarasini A, Tassis B, Rustico M, Quarenghi A et al (2016) Diagnostic and prognostic value of molecular and serological investigation of human parvovirus B19 infection during pregnancy. New Microbiol 39(3):181–185

  47. Zhi N, Mills IP, Lu J, Wong S, Filippone C, Brown KE (2006) Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 80(12):5941–5950

  48. Zhi N, Zádori Z, Brown KE, Tijssen P (2004) Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318(1):142–152

Download references

Acknowledgements

The authors acknowledge Bon Yakhteh Stem Cell Technology Research Center for technical assistance.

Author information

Correspondence to Nematollah Gheibi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Amiri, S., Atashi, A., Azad, M. et al. Upregulation of Pro-inflammatory Cytokine Genes by Parvovirus B19 in Human Bone Marrow Mesenchymal Stem Cells. Biochem Genet 58, 63–73 (2020). https://doi.org/10.1007/s10528-019-09928-y

Download citation

Keywords

  • Bone marrow
  • Chronic inflammation
  • Infection
  • Mesenchymal stem cell
  • Parvovirus B19